Thursday 15th November 2018
5 tips for staying healthy this winter
Staying Healthy in the cold can be especially hard when living with Scleroderma and Raynaud’s. Here are some top tips for keeping warm with your conditions this winter.
Monday 12th November 2018
7 handy hints for keeping warm this winter
Keeping warm in winter, for many, is often not as easy as turning up the heater. Here are some helpful tips that will prevent illness worsening in the colder months and keep your body healthy.
Thursday 8th November 2018
Is gastroesophageal reflux contributing to lung scarring?
A research collaboration between the Royal Free and Royal Brompton hospitals, funded by Scleroderma and Raynaud’s UK (SRUK), is investigating if reflux from the stomach into the oesophagus plays a role in lung scarring in scleroderma patients.
Tuesday 6th November 2018
Is there a link between Localised and Systemic Scleroderma?
Keloid morphea is a rare, and hence poorly understood, form of localised scleroderma that only affects the skin. A new study into the condition has the potential to make a huge beneficial impact on our community.
Friday 2nd November 2018
Alternative Therapies: Do they help Raynaud’s?
Over the years, many people living with Raynaud’s have advocated for the use of Chinese acupuncture and Chinese acupressure, but do they actually help?
Tuesday 30th October 2018
Tenascin-C: A potential driving factor of organ fibrosis
Fibrosis is often the fundamental reason of morbidity and mortality in systemic scleroderma, however there is no effective therapy to prevent this process. A new study has identified a protein that may trigger fibrosis.
Friday 26th October 2018
SRUK launches online Raynaud’s test to aid in diagnosis
In a bid to raise awareness of Raynaud’s phenomenon (RP) and to encourage individuals to be actively involved in their own healthcare, SRUK led an initiative to develop a ‘Raynaud’s test’ on their website for the online audience.
Monday 22nd October 2018
SRUK commits to funding a pre-clinical study to evaluate a novel and innovative therapy to treat fibrosis
Skin fibrosis can be a severe and life limiting complication of scleroderma, with a dramatic impact on quality of life. It can be progressive and painful, leading to permanent ulcers and restriction of movement. Being able to limit the progression of skin fibrosis, and ultimately, reverse the effects are a key priority for SRUK and our community.
Wednesday 17th October 2018
Is there a better way to differentiate Primary and Secondary Raynaud’s?
A study from Japan has devised a test which researchers claim could prove whether a patient has primary or secondary Raynaud’s.
Tuesday 9th October 2018
EULAR calls for Horizon Europe budget increase to meet citizens’ needs
The European League Against Rheumatism (EULAR) has issued a call to the European institutions together with the biomedical research community to make Horizon Europe a success for Europe’s long-term health.